CHAI also introduced the Assurance Lab Certification Framework, which will create a network of independent labs to evaluate and certify AI models used in healthcare. According to Dr. Anderson, this ...

The global R&D pipeline is dominated by potential treatments in oncology and this is also where ... R&D candidates that pharma is looking into is AI technology. Last year, a drug candidate ...

The logo of AstraZeneca is seen ... Chief Data Scientist, Oncology R&D at AstraZeneca, emphasized the transformative impact of AI in clinical development, stating, “Artificial intelligence ...

Those funds have helped the company stretch its reach from immuno-oncology toward broader research ... both through its AMICA cell atlas and its AI model dubbed the Immunodynamics Engine, or ...

Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...

The firms aim to use Azure AI to process clinical notes, lab tests, genomic data, images, and other often inaccessible data to identify personalized treatments.

Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology Orion Corporation and Aitia, an AI-enabled biotechnology company and the leader in the development and ...

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development. The partnership aims to leverage Tempus' multimodal real-world datasets and biological ...

Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study D.H.O. receives research support from the NIH (R01CA273924) ...

This study investigates the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) derived from blood plasma to detect key copy number alterations (CNAs) in lung cancer patients. CNAs ...